New discoveries in chemical research and development in 2021. The appropriate choice of redox mediator can avoid electrode passivation and overpotential, which strongly inhibit the efficient activation of substrates in electrolysis. In a patent, 86028-91-3, name is (R)-Ethyl thiazolidine-4-carboxylate hydrochloride, introducing its new discovery. Recommanded Product: 86028-91-3
The synthesis of heterocyclic analogues of the platelet activating factor is described.The preparation starts with acylating rac-tetrahydro-1,3-thiazine-4-carboxylic acid ethyl ester, with palmitoyl chloride to form the amide linkage.Following ester reduction, the phosphocholine part is introduced via 2-chloro-2-oxo-1,3,2-dioxaphospholane and subsequent ring opening with trimethylamine under pressure.Furthermore, the related L-thiazolidine analogue is prepared using the same procedure.In addition the sulfinyl and sulfonyl derivatives of this compound are obtained by oxidation with 3-chloro-perbenzoic acid.From one sulfinyl intermediate the diastereomeres are separated and their conformations are determined by 13C-NMR spectroscopy. Keywords: Phospholipid synthesis; Cyclic platelet activating factor analogue; Cyclic thioether; Chiral sulphur compound
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Recommanded Product: 86028-91-3, you can also check out more blogs about86028-91-3
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H791N | ChemSpider